• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同的肝脏免疫模式与肝细胞癌的进展或抑制有关。

Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma.

机构信息

Department of Internal Medicine, VCU School of Medicine, Richmond, VA 23298, USA.

Department of Internal Medicine, VCU School of Medicine, Richmond, VA 23298, USA; VCU Massey Cancer Center, 401 College Street, Richmond, VA 23298, USA; College of Science, Mustansiriyah University, Baghdad, Iraq.

出版信息

Cell Rep. 2022 Mar 1;38(9):110454. doi: 10.1016/j.celrep.2022.110454.

DOI:10.1016/j.celrep.2022.110454
PMID:35235789
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9028248/
Abstract

To discover distinct immune responses promoting or inhibiting hepatocellular carcinoma (HCC), we perform a three-dimensional analysis of the immune cells, correlating immune cell types, interactions, and changes over time in an animal model displaying gender disparity in nonalcoholic fatty liver disease (NAFLD)-associated HCC. In response to a Western diet (WD), animals mount acute and chronic patterns of inflammatory cytokines, respectively. Tumor progression in males and females is associated with a predominant CD8 CD4, Th1 > Th17 > Th2, NKT > NK, M1 > M2 pattern in the liver. A complete rescue of females from HCC is associated with an equilibrium Th1 = Th17 = Th2, NKT = NK, M1 = M2 pattern, while a partial rescue of males from HCC is associated with an equilibrium CD8 = CD4, NKT = NK and a semi-equilibrium Th1 = Th17 > Th2 but a sustained M1 > M2 pattern in the liver. Our data suggest that immunological pattern-recognition can explain immunobiology of HCC and guide immune modulatory interventions for the treatment of HCC in a gender-specific manner.

摘要

为了发现促进或抑制肝细胞癌(HCC)的独特免疫反应,我们对免疫细胞进行了三维分析,将动物模型中不同性别之间非酒精性脂肪性肝病(NAFLD)相关 HCC 的免疫细胞类型、相互作用以及随时间的变化进行了关联。在对西方饮食(WD)的反应中,动物分别产生急性和慢性炎症细胞因子模式。在男性和女性中,肿瘤的进展与肝脏中占主导地位的 CD8 CD4、Th1 > Th17 > Th2、NKT > NK、M1 > M2 模式相关。女性完全免受 HCC 的影响与 Th1 = Th17 = Th2、NKT = NK、M1 = M2 模式的平衡相关,而男性部分免受 HCC 的影响与 CD8 = CD4、NKT = NK 的平衡以及 Th1 = Th17 > Th2 的半平衡相关,但 M1 > M2 模式在肝脏中持续存在。我们的数据表明,免疫模式识别可以解释 HCC 的免疫生物学,并以性别特异性的方式指导免疫调节干预治疗 HCC。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8005/9028248/c0f1724edbd2/nihms-1785222-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8005/9028248/7a688cd8fce0/nihms-1785222-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8005/9028248/37d0d0c205a9/nihms-1785222-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8005/9028248/78a80977620d/nihms-1785222-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8005/9028248/f778bff6dba0/nihms-1785222-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8005/9028248/c0f1724edbd2/nihms-1785222-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8005/9028248/7a688cd8fce0/nihms-1785222-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8005/9028248/37d0d0c205a9/nihms-1785222-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8005/9028248/78a80977620d/nihms-1785222-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8005/9028248/f778bff6dba0/nihms-1785222-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8005/9028248/c0f1724edbd2/nihms-1785222-f0006.jpg

相似文献

1
Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma.不同的肝脏免疫模式与肝细胞癌的进展或抑制有关。
Cell Rep. 2022 Mar 1;38(9):110454. doi: 10.1016/j.celrep.2022.110454.
2
The crosstalking immune cells network creates a collective function beyond the function of each cellular constituent during the progression of hepatocellular carcinoma.在肝细胞癌进展过程中,相互交流的免疫细胞网络创造了一种超越每个细胞成分功能的集体功能。
Sci Rep. 2023 Aug 3;13(1):12630. doi: 10.1038/s41598-023-39020-w.
3
Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.利用动物模型研究非酒精性脂肪性肝炎相关的肝细胞癌。
Oncotarget. 2016 Jul 5;7(27):42762-42776. doi: 10.18632/oncotarget.8641.
4
Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma.非酒精性脂肪性肝炎与肝细胞癌的免疫学区别。
Exp Mol Med. 2020 Aug;52(8):1209-1219. doi: 10.1038/s12276-020-0480-3. Epub 2020 Aug 7.
5
Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.两种非酒精性脂肪性肝病膳食小鼠模型引起的代谢和肝脏病理生物学差异。
Am J Physiol Endocrinol Metab. 2020 Nov 1;319(5):E863-E876. doi: 10.1152/ajpendo.00321.2020. Epub 2020 Sep 14.
6
Nonalcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
7
Fatty Liver Disease and Hepatocellular Carcinoma: The Pathologist's View.脂肪性肝病与肝细胞癌:病理医师的视角。
Adv Exp Med Biol. 2018;1032:55-69. doi: 10.1007/978-3-319-98788-0_4.
8
NASH limits anti-tumour surveillance in immunotherapy-treated HCC.NASH 限制了免疫治疗治疗 HCC 的肿瘤监测。
Nature. 2021 Apr;592(7854):450-456. doi: 10.1038/s41586-021-03362-0. Epub 2021 Mar 24.
9
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.高脂饮食诱导的非酒精性脂肪性肝病-非酒精性脂肪性肝炎-肝细胞癌进展中的微小RNA表达分析:对C57BL/6J小鼠的研究
BMC Cancer. 2016 Jan 5;16:3. doi: 10.1186/s12885-015-2007-1.
10
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.

引用本文的文献

1
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy.肝细胞癌中的免疫微环境:从发病机制到免疫治疗
Cell Mol Immunol. 2025 Jun 11. doi: 10.1038/s41423-025-01308-4.
2
Anti-Tumour Immunity Relies on Targeting Tissue Homeostasis Through Monocyte-Driven Responses Rather Than Direct Tumour Cytotoxicity.抗肿瘤免疫依赖于通过单核细胞驱动的反应靶向组织稳态,而非直接的肿瘤细胞毒性。
Liver Int. 2025 May;45(5):e70110. doi: 10.1111/liv.70110.
3
CCL26 as a prognostic biomarker in hepatocellular carcinoma: integrating bioinformatics analysis, clinical validation, and radiomics score.

本文引用的文献

1
Pattern recognition of tumor dormancy and relapse beyond cell-intrinsic and cell-extrinsic pathways.超越细胞内在和外在途径的肿瘤休眠与复发的模式识别
Semin Cancer Biol. 2022 Jan;78:1-4. doi: 10.1016/j.semcancer.2021.12.008. Epub 2022 Jan 3.
2
The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases.代谢性疾病中 Th17/Treg 平衡的改变及其作用。
Front Immunol. 2021 Jul 12;12:678355. doi: 10.3389/fimmu.2021.678355. eCollection 2021.
3
NASH limits anti-tumour surveillance in immunotherapy-treated HCC.
CCL26作为肝细胞癌的预后生物标志物:整合生物信息学分析、临床验证和影像组学评分
Discov Oncol. 2025 Apr 9;16(1):502. doi: 10.1007/s12672-025-02280-1.
4
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals.与埃及丙型肝炎病毒肝硬化患者直接作用抗病毒治疗前后肝癌发生风险相关的外周免疫特征。
Virol J. 2024 Nov 15;21(1):293. doi: 10.1186/s12985-024-02551-3.
5
JDF promotes the apoptosis of M2 macrophages and reduces epithelial-mesenchymal transition and migration of liver cancer cells by inhibiting CSF-1/PI3K/AKT signaling pathway.JDF通过抑制CSF-1/PI3K/AKT信号通路促进M2巨噬细胞凋亡,并减少肝癌细胞的上皮-间质转化和迁移。
Heliyon. 2024 Aug 2;10(15):e34968. doi: 10.1016/j.heliyon.2024.e34968. eCollection 2024 Aug 15.
6
From MASLD to HCC: What's in the middle?从代谢相关脂肪性肝病到肝细胞癌:中间环节是什么?
Heliyon. 2024 Jul 31;10(15):e35338. doi: 10.1016/j.heliyon.2024.e35338. eCollection 2024 Aug 15.
7
Sphingosine kinase 2 and p62 regulation are determinants of sexual dimorphism in hepatocellular carcinoma.鞘氨醇激酶 2 和 p62 调节是肝癌性别二态性的决定因素。
Mol Metab. 2024 Aug;86:101971. doi: 10.1016/j.molmet.2024.101971. Epub 2024 Jun 24.
8
Anti-tumor immunity relies on targeting tissue homeostasis through monocyte-driven responses rather than direct tumor cytotoxicity.抗肿瘤免疫依赖于通过单核细胞驱动的反应来靶向组织稳态,而非直接的肿瘤细胞毒性。
bioRxiv. 2025 Mar 6:2024.06.12.598563. doi: 10.1101/2024.06.12.598563.
9
Decoding the role of immune T cells: A new territory for improvement of metabolic-associated fatty liver disease.解读免疫T细胞的作用:改善代谢相关脂肪性肝病的新领域。
Imeta. 2023 Jan 18;2(1):e76. doi: 10.1002/imt2.76. eCollection 2023 Feb.
10
Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus.独特的辅助性T细胞介导的抗肿瘤免疫:聚焦辅助性T2细胞
Cancer Pathog Ther. 2022 Nov 4;1(1):76-86. doi: 10.1016/j.cpt.2022.11.001. eCollection 2023 Jan.
NASH 限制了免疫治疗治疗 HCC 的肿瘤监测。
Nature. 2021 Apr;592(7854):450-456. doi: 10.1038/s41586-021-03362-0. Epub 2021 Mar 24.
4
4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in mice.4-甲基伞形酮介导的 M1 巨噬细胞极化与小鼠肝癌侵袭性降低相关。
Sci Rep. 2021 Mar 18;11(1):6310. doi: 10.1038/s41598-021-85491-0.
5
Patterns of dendritic cell and monocyte subsets are associated with disease severity and mortality in liver cirrhosis patients.树突状细胞和单核细胞亚群的模式与肝硬化患者的疾病严重程度和死亡率相关。
Sci Rep. 2021 Mar 15;11(1):5923. doi: 10.1038/s41598-021-85148-y.
6
Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus.伴有乙型或丙型肝炎病毒感染的肝细胞癌的免疫治疗
Hepatoma Res. 2020;6. doi: 10.20517/2394-5079.2020.58. Epub 2020 Oct 12.
7
A Double Edged Sword Role of Interleukin-22 in Wound Healing and Tissue Regeneration.白细胞介素-22 在创伤愈合和组织再生中的双刃剑作用。
Front Immunol. 2020 Sep 17;11:2148. doi: 10.3389/fimmu.2020.02148. eCollection 2020.
8
M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer.基于转录组特征定义的 M1 巨噬细胞和 M1/M2 比值仅部分类似于乳腺癌的传统临床特征。
Sci Rep. 2020 Oct 6;10(1):16554. doi: 10.1038/s41598-020-73624-w.
9
LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells.长链非编码RNA FTX通过调节枯否细胞的M1/M2极化来抑制非酒精性脂肪性肝病向肝细胞癌的进展。
Cancer Cell Int. 2020 Jun 24;20:266. doi: 10.1186/s12935-020-01354-0. eCollection 2020.
10
Molecular principles of metastasis: a hallmark of cancer revisited.转移的分子原理:重新审视癌症的一个标志
Signal Transduct Target Ther. 2020 Mar 12;5(1):28. doi: 10.1038/s41392-020-0134-x.